Polyinosinic:polycytidylic acid - PrEP Biopharm

Drug Profile

Polyinosinic:polycytidylic acid - PrEP Biopharm

Alternative Names: JNJ 43260295 AAM; Poly I: Poly C; Poly IC; Poly-ICLC - PrEP Biopharm; Polyinosinic-polycytidylic acid sodium salt; PrEP 001; Product Number WO 643

Latest Information Update: 12 Jul 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Janssen Sciences Ireland UC
  • Developer hVIVO; Janssen Research & Development; Janssen Sciences Ireland UC; PrEP Biopharm
  • Class Adjuvants; Antineoplastics; Antivirals; Biopolymers; Oligonucleotides
  • Mechanism of Action 2',5' oligoadenylate synthetase modulators; DDX58 protein modulators; IFIH1 protein modulators; Immunomodulators; Proto oncogene protein c rel modulators; Toll-like receptor 3 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Influenza virus infections; Rhinovirus infections

Most Recent Events

  • 18 May 2018 Interim Safety and efficacy results from the phase IIa trial presented at the 114th International Conference of the American Thoracic Society (ATS-2018)
  • 24 May 2017 Prep Biopharm completes a phase I trial in Healthy volunteers in United Kingdom (NCT03198676)
  • 08 May 2017 Prep Biopharm initiates enrolment in a phase I trial in Healthy volunteers in United Kingdom (NCT03198676)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top